The Cost-Effectiveness of Antiretroviral Therapy for Treating HIV Disease in the Caribbean

Abstract

In the OECS, ART is cost-effective by international standards. Reducing second-line ART costs increases cost-effectiveness and affordability. Current funding supports implementing universal access regionally over the next year, but additional funding is required to sustain lifetime care for currently infected persons.